Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07062978 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a multicenter, randomized, double-blind comparative study to valuating the efficacy and safety of QL1206 and Prolia® in postmenopausal women with osteoporosis at high risk of fracture.
Trial Details
NCT Number NCT07062978
Lead Sponsor Qilu Pharmaceutical Co., Ltd.
Conditions Postmenopausal Women With Osteoporosis at High Risk of Fracture
Enrollment 278 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov